Clinical Topics & News

Screening for Psoriatic Arthritis in Psoriasis Patients

Dr. Khattri is Instructor in the Department of Dermatology and Director of the Rheumatology-Dermatology Clinic at Mount Sinai Medical Center in New York, New York.



Delayed diagnosis of psoriatic arthritis (PsA) can have profound effects, such as irreversible joint damage, poor quality of life, and decreased response to treatment; however, many cases of PsA are not diagnosed until up to 2 years after onset of symptoms. Dr. Saakshi Khattri discusses screening questions for PsA that dermatologists should address when treating patients with psoriasis and emphasizes that collaboration between dermatologists and rheumatologists is essential to early diagnosis and treatment of PsA.

The psoriasis audiocast series is created in collaboration with Cutis® and the National Psoriasis Foundation®.

Recommended Reading

WCD: IL-23p19 inhibitors yield ‘promising’ psoriasis results
Psoriasis Collection
WCD: Secukinumab shows effectiveness for nail, palmoplantar psoriasis
Psoriasis Collection
EULAR’s psoriatic arthritis recommendations gain new drugs
Psoriasis Collection
Clinical Trial Update: Topical Therapy for Plaque Psoriasis
Psoriasis Collection
Guselkumab prevails in phase II psoriasis trial
Psoriasis Collection

Related Articles